Área de Asma SEPAR retweeted
Replying to @EuroRespSoc
@EuroRespSoc #ERSCongress #ERS2022 Pre-congress content: #Biologics in #asthma: do we need so many and who do we miss? #GuyBrusselle @ALAT_Asma @gemasma @ginasthma @asthma_papers @AsmaSEPAR @SeparJovenes
Área de Asma SEPAR retweeted
A proposal to incorporate #oracle (oraclescore.com/en) and #FeNO suppression test as precision medicine tools in the difficult-to-treat #asthma patient before using #biologic therapy. @Majito25MD @simcouillard @ALAT_Asma @ginasthma @AsmaSEPAR @gemasma @asthma_papers
Área de Asma SEPAR retweeted
#Asthma in adults and adolescents should not be managed solely with short-acting β2-agonist relievers (SABAs). ginasthma.org/reports
Área de Asma SEPAR retweeted
#Asthma is a heterogenous disease. Targeted therapies have been developed based on the pathophysiology of type 2 inflammation. These therapies offer hope for improved management of T2 airway diseases. bit.ly/3HCkrvQ @ArzuYorgancolu @HUSI_Investiga @ALAT_Asma @ginasthma
Área de Asma SEPAR retweeted
Predictors and associations of the persistent #airflow limitation #phenotype in #asthma: a post-hoc analysis of the #ATLANTIS study thelancet.com/journals/lanre… @simcouillard @traitsCRE @ALAT_Asma @gemasma @ginasthma @Majito25MD @AsmaSEPAR
Área de Asma SEPAR retweeted
SEPAR's Archivos de Bronconeumología has achieved an impact factor of 6.33 points, which once again places it in the first quartile (Q1) of journals dedicated to respiratory pathology.
👇 Do not miss it!
🔗 archbronconeumol.org/?codref…
#SEPARrespira #BronconeumolgyArchives
El próximo otoño dará comienzo el 2º curso de asma grave de SEPAR. En las próximas semanas os informaremos sobre cómo inscribiros. ¡Estad atentos!
El Área de Asma de @SeparRespira comienza su andadura en Twitter. Desde aquí informaremos de las principales novedades en el área. ¡Follow para no perderos nada!
#neumologia #asma #separ











